ACTR-34. SINGLE AGENT ONC201 IN PREVIOUSLY-TREATED, PROGRESSIVE ADULT H3 K27M-MUTANT GLIOMA

MLA

Isabel Arrillaga-Romany, et al. “Actr-34. Single Agent Onc201 in Previously-Treated, Progressive Adult H3 K27m-Mutant Glioma.” Neuro-Oncology, vol. 21, Nov. 2019, pp. vi20-vi21. EBSCOhost, https://doi.org/10.1093/neuonc/noz175.077.

APA

Isabel Arrillaga-Romany, Patrick Y. Wen, Yoshie Umemura, Timothy F. Cloughesy, John DeGroot, Erik P. Sulman, Andrew B. Lassman, Tracy T. Batchelor, Andrew S. Chi, Rohinton Tarapore, Rebecca Harrison, Nicholas Butowski, Nicole Shonka, Joshua E. Allen, P Leia Nghiemphu, Krystal Merdinger, Sylvia Kurz, Minesh P. Mehta, Ashley Sumrall, … Wolfgang Oster. (2019). Actr-34. Single Agent Onc201 in Previously-Treated, Progressive Adult H3 K27m-Mutant Glioma. Neuro-Oncology, 21, vi20-vi21. https://doi.org/10.1093/neuonc/noz175.077

Chicago

Isabel Arrillaga-Romany, Patrick Y. Wen, Yoshie Umemura, Timothy F. Cloughesy, John DeGroot, Erik P. Sulman, Andrew B. Lassman, et al. 2019. “Actr-34. Single Agent Onc201 in Previously-Treated, Progressive Adult H3 K27m-Mutant Glioma.” Neuro-Oncology 21 (November): vi20-vi21. doi:10.1093/neuonc/noz175.077.